Is AN2 Therapeutics, Inc. overvalued?

AN2 Therapeutics, Inc. (ANTX) — key valuation metrics and fundamentals.

No verdict

Price

$5.01

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$180.4M

Dividend yield

0.0%

Return on equity

-53.5%

Sector

Healthcare

Fair value compares ANTX's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.

Related stocks